Remove tag blood-brain-barrier
article thumbnail

First gene therapy trial for Hunter syndrome opens in Manchester, UK

Drug Discovery World

The children will continue to receive enzyme replacement therapy during treatment, but once the gene therapy begins to work, the research team say part of the trial aims to remove the need for weekly enzyme replacement therapy over the child’s lifetime, while the other aim is to safely target the brain disease suffered by these patients.